STOCK TITAN
  1. Home
  2. News
  3. A

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc., originally spun out of Hewlett-Packard in 1999, has evolved into a leading firm in the life sciences and diagnostics sector. The company specializes in creating advanced measurement technologies that serve a vast range of customers across various industries.

The company's core business revolves around three main segments: life science and applied tools, cross lab (which includes consumables and services related to life sciences and applied tools), and diagnostics and genomics. These segments collectively cater to a broad spectrum of markets, including biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government-related organizations.

Agilent's geographical reach is extensive, with significant operations in the U.S. and China. The company is committed to addressing global trends impacting human health and the environment and continuously anticipates future scientific needs.

Agilent provides comprehensive laboratory solutions that enhance the efficiency of laboratories, from sample preparation to data interpretation and management. Their instruments, software, services, and consumables are designed to meet the most complex laboratory demands, empowering scientists and researchers worldwide to make impactful discoveries and improvements in various fields.

Recent achievements include advancements in biopharmaceutical technology, collaborations with leading research institutions, and the launch of state-of-the-art diagnostic tools. The company also emphasizes sustainable practices and innovations aimed at improving human health and environmental outcomes.

News

Agilent Resolve Raman Receives Multiple Recognitions for HazMat and CBRN Excellence

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announced that the Agilent Resolve Handheld Raman Spectrometer has been recognized for excellence as a tool for emergency responders by the UK’s National CBRN Centre and the US’ Department of Homeland Security.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
none
-
News

Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) introduces water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader. These features enhance image quality for live-cell and 3D applications, reducing deleterious effects on live-cell samples and improving clarity for thicker samples such as tissues and 3-D spheroids.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
none
-
News

Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) reported revenue of $1.69 billion for Q4 2023, down 8.7% reported and 9.7% core(1) from Q4 2022. GAAP net income was $475 million; EPS was $1.62, up 32% from Q4 2022. Full fiscal year 2023 revenue was $6.83 billion, flat on a reported basis and up 1.5% core(1) year-over-year. For fiscal year 2024, revenue is expected between $6.71 billion to $6.81 billion, and non-GAAP EPS in the range of $5.44 to $5.55 per share.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.72%
Tags
earnings
News

Agilent to Present at the Evercore ISI HealthCONx Conference

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) to present at Evercore ISI HealthCONx conference on Nov. 29. President and CEO, Mike McMullen, and CFO, Bob McMahon, will lead the virtual session. The webcast will be available on Agilent's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
conferences
-
News

Agilent Increases Cash Dividend to 23.6 Cents per Share

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) Increases Quarterly Dividend by 5% to 23.6 Cents Per Share
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
dividends
-
News

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has received FDA approval for PD-L1 IHC 22C3 pharmDx as a diagnostic tool to identify patients with Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma eligible for treatment with KEYTRUDA® (pembrolizumab). This marks the sixth cancer type for which PD-L1 IHC 22C3 pharmDx has gained FDA approval, highlighting Agilent's leadership in developing companion diagnostics for anti-PD-1 therapies. PD-L1 IHC 22C3 pharmDx also aids in identifying patients with non-small cell lung cancer, esophageal squamous cell carcinoma, cervical cancer, head and neck squamous cell carcinoma, and triple-negative breast cancer suitable for treatment with KEYTRUDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.86%
Tags
fda approval
News

Agilent Announces Thought Leader Award to Professor Jennifer Field

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announces Jennifer Field, an Oregon State University researcher, as the recipient of the Agilent Thought Leader Award for her pioneering work with organic micropollutants and PFAS. Dr. Field's research focuses on the quantitative analysis of PFAS compounds, known as 'forever chemicals', and their environmental implications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
-
News

Tele2 enables sustainable forestry with AirForestry and Nokia 5G Private Wireless

Rhea-AI Summary
Tele2 AB (NASDAQ: TEL2 A) and (NASDAQ: TEL2 B) in partnership with Nokia, announces the delivery of a 5G private mobile network to AirForestry for controlling electric drones used in forest thinning. The pilot project, running in 2024, aims to introduce the solution into commercial forestry operations. The technology promises to revolutionize forest harvesting, offering efficient and sustainable solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
none
-
News

Crawford & Company Reports 2023 Third Quarter Results

Rhea-AI Summary
Crawford & Company announces record quarterly revenue in Q3 2023, with revenues before reimbursements of $325.6 million, up 10% from the same period last year. Net income attributable to shareholders was $12.3 million, compared to a loss of $15.1 million in Q3 2022. Diluted earnings per share were $0.25 for both CRD-A and CRD-B, compared to a diluted loss per share of $(0.31) in the prior year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.8%
Tags
earnings
News

Fred R. Donner Elected to Crawford & Company® Board of Directors

Rhea-AI Summary
Crawford & Company has announced the election of Fred R. Donner as an independent director, effective November 3, 2023. With almost 40 years of experience in the insurance industry, Mr. Donner brings expertise in leading and advising corporations through restructurings, international expansion, risk management, and capital market transactions. His addition to the board strengthens the company's commitment to leveraging deep industry expertise.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
management

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $133.84 as of November 22, 2024.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 38.0B.

What does Agilent Technologies Inc. specialize in?

Agilent specializes in life sciences, diagnostics, and measurement technologies, providing advanced solutions and services for laboratories.

When was Agilent Technologies Inc. founded?

Agilent Technologies was spun out of Hewlett-Packard in 1999.

What are the main business segments of Agilent Technologies Inc.?

Agilent operates in three main segments: life science and applied tools, cross lab, and diagnostics and genomics.

Which industries does Agilent Technologies Inc. serve?

Agilent serves industries such as biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government organizations.

Where are Agilent Technologies Inc.'s main operations located?

Agilent's main operations are located in the U.S. and China.

What recent achievements has Agilent Technologies Inc. made?

Recent achievements include advancements in biopharmaceutical technology, collaborations with research institutions, and new diagnostic tools.

How does Agilent Technologies Inc. contribute to laboratory efficiency?

Agilent enhances laboratory efficiency through comprehensive solutions for sample preparation, data interpretation, and management.

What sustainable practices does Agilent Technologies Inc. emphasize?

Agilent focuses on innovations that improve human health and environmental outcomes, emphasizing sustainability in its practices.

Why do scientists and researchers trust Agilent Technologies Inc.?

Scientists and researchers trust Agilent for its reliable solutions that meet complex laboratory demands and enable significant insights.

What kind of global issues does Agilent Technologies Inc. address?

Agilent addresses global issues related to human health and the environment, anticipating future scientific needs.

Stock A logo
Agilent Technologies Inc.

NYSE:A

A Rankings

#344 Ranked by Market Cap
#1914 Ranked by Dividends

A Stock Data

38.05B
286.42M
0.27%
91.2%
1.2%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
SANTA CLARA